IESE (España)
-
Public hospital self-government and competitiveness in the Santa Fe de Bogotá health services market
Gallardo H. M.; Morales L. G.; Pancorvo J.; Rosenmöller, MagdaCase P-1002-EService and Operations ManagementSince the beginning of the decade, Colombia has been implementing an in-depth reform of the health system, advocating independent administrative and financial management of public hospitals within a framework of competition between health service providers. The country's capital city, Santa Fe de Bogotá, has 32 public hospitals which, in 1997, were set up as state social enterprises, implementing independent management systems. The case analyzes ...Starting at €8.20
-
Autonomía y competitividad de los hospitales públicos en el mercado de servicios de Salud de Santa Fe de Bogotá
Gallardo H. M.; Morales L. G.; Pancorvo J.; Rosenmöller, MagdaCase P-1002Service and Operations ManagementEn esta década, Colombia viene desarrollando una profunda reforma del sistema de salud, propugnando la gestión autónoma - administrativa y financiera - de los hospitales públicos en un marco de competencia entre prestadores del servicio de salud. La capital, Santa Fe de Bogotá, cuenta con 32 hospitales públicos habiéndose constituido, en 1997, como Empresas Sociales del Estado accediendo al régimen de autonomía. Se analiza la problemática existen...Starting at €8.20
-
A Walk Through the United States
Bardolet Urgellès, David; Baucells Alibés, Manel; Ariño, Miguel AngelCase AD-374-EDecision Analysis, EconomicsThe case presents the well-known traveling salesman problem in the context of having to visit 48 U.S. State Capitals.Starting at €8.20
-
Un paseo por Estados Unidos
Bardolet Urgellès, David; Baucells Alibés, Manel; Ariño, Miguel AngelCase AD-374Decision Analysis, EconomicsEl caso presenta el bien conocido problema del representante en el contexto de visitar 48 ciudades de Estados Unidos.Starting at €8.20
-
Glaxo: The acquisition of Wellcome
Canals, Jordi; Bardolet Urgellès, DavidCase ASE-386-EEconomicsThis case describes the changes in the world pharmaceutical industry in 1995 and presents the challenges for Glaxo (the leading European pharmaceutical firm) and the potential acquisition of Wellcome. This decision will differ from other acquisitions made by firms like Merck, oriented towards vertical integration and control over the distribution network. The main topics that the case covers are: industry analysis; value chain analysis; positioni...Starting at €8.20